taxonomy (8)
protein (97)
source (28)
structure (39)
composition (1)
disease (12)
reference (45)
site (124)
peptide (98)
- Homo sapiens (Human)
- Mus musculus (House mouse)
- Ovis aries (Sheep)
- Rattus norvegicus (Norway rat)
- Sus scrofa (Pig)
- Gallus gallus (Chicken)
- Calloselasma rhodostoma (Malayan pit viper)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- Alpha-2-macroglobulin / Homo sapiens P01023
- Angiotensin-converting enzyme 2 / Homo sapiens Q9BYF1
- Asporin / Homo sapiens Q9BXN1
- Beta-hexosaminidase subunit alpha / Homo sapiens P06865
- Biglycan / Homo sapiens P21810
- Cadherin EGF LAG seven-pass G-type receptor 1 / Homo sapiens Q9NYQ6
- Cadherin-5 / Homo sapiens P33151
- Calumenin / Homo sapiens O43852
- Calumenin, isoform CRA_a / Homo sapiens
- Cartilage oligomeric matrix protein / Homo sapiens P49747
- Cathepsin F / Homo sapiens Q9UBX1
- CD16A-NK13-V/F genotype / Homo sapiens P08637
- CD59 glycoprotein / Homo sapiens P13987
- Clusterin / Homo sapiens P10909
- Coagulation factor V / Homo sapiens P12259
- Collagen alpha-1(XII) chain / Homo sapiens Q99715
- Collagen alpha-1(XIV) chain / Homo sapiens Q05707
- Decorin / Homo sapiens P07585
- Desmoglein-2 / Homo sapiens Q14126
- Erythropoietin / Homo sapiens P01588
- Extracellular matrix protein 1 / Homo sapiens Q16610
- Extracellular sulfatase Sulf-1 / Homo sapiens Q8IWU6
- Fibromodulin / Homo sapiens Q06828
- Fibronectin / Homo sapiens P02751
- Galectin-3-binding protein / Homo sapiens Q08380
- Glycodelin-a / Homo sapiens P09466
- High affinity immunoglobulin gamma Fc receptor I / Homo sapiens P12314-2
- HLA class I histocompatibility antigen, B-35 alpha chain / Homo sapiens P30685
- HLA class I histocompatibility antigen, B-44 alpha chain / Homo sapiens P30481
- HLA class I histocompatibility antigen, B-53 alpha chain / Homo sapiens P30491
- HLA class I histocompatibility antigen, B-58 alpha chain / Homo sapiens P10319
- HLA class I histocompatibility antigen, Cw-15 alpha chain / Homo sapiens Q07000
- HLA class I histocompatibility antigen, Cw-3 alpha chain / Homo sapiens P04222
- Immunoglobulin epsilon chain c region / Homo sapiens P01854
- Immunoglobulin gamma / Homo sapiens P01859 P01861 P01860 P01857
- Immunoglobulin heavy constant alpha 1 / Homo sapiens P01876
- Immunoglobulin heavy constant alpha 2 / Homo sapiens P01877
- Immunoglobulin heavy constant delta / Homo sapiens P01880
- Immunoglobulin heavy constant delta - heavy chain 1 / Homo sapiens P01880
- Immunoglobulin heavy constant delta - heavy chain 2 / Homo sapiens P01880
- Immunoglobulin heavy constant epsilon - heavy chain 1 / Homo sapiens P01854
- Immunoglobulin heavy constant epsilon - heavy chain 2 / Homo sapiens P01854
- Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant A121N / Homo sapiens P01857
- Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens P01857
- Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant T198N / Homo sapiens P01857
- Immunoglobulin heavy constant mu / Homo sapiens P01871
- Immunoglobulin J chain / Homo sapiens P01591
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens Q14624
- Interstitial collagenase / Homo sapiens P03956
- Keratin, type II cytoskeletal 8 / Homo sapiens P05787
- Kininogen-1 / Homo sapiens P01042
- Lactotransferrin / Homo sapiens P02788
- Laminin subunit alpha-4 / Homo sapiens Q16363
- Low affinity immunoglobulin gamma Fc region receptor II-a (FcγRIIa ) / Homo sapiens P12318-1
- Low affinity immunoglobulin gamma Fc region receptor II-b (FcγRIIb ) / Homo sapiens P31994-3
- Low affinity immunoglobulin gamma Fc region receptor III-A (FcγRIIIa ) / Homo sapiens P08637
- Low affinity immunoglobulin gamma Fc region receptor III-B (FcγRIIIb ) / Homo sapiens O75015
- Lumican / Homo sapiens P51884
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens P13473
- Matrilin-4 / Homo sapiens O95460
- Mesothelin / Homo sapiens Q13421
- Metalloproteinase inhibitor 1 / Homo sapiens P01033
- Nephronectin / Homo sapiens Q6UXI9
- Olfactomedin-like protein 3 / Homo sapiens Q9NRN5
- Palmitoyl-protein thioesterase 1 / Homo sapiens P50897
- Periostin / Homo sapiens Q15063
- Phospholipase B-like 1 / Homo sapiens Q6P4A8
- Polymeric immunoglobulin receptor / Homo sapiens P01833
- Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 / Homo sapiens O00469
- Prominin-1 / Homo sapiens O43490
- Prosaposin / Homo sapiens P07602
- Prostaglandin F2 receptor negative regulator / Homo sapiens Q9P2B2
- Prostaglandin-h2 d-isomerase / Homo sapiens P41222
- Prostate-specific antigen (psa-1) / Homo sapiens P07288
- Prostate-specific antigen - high Pi isoform (psah) / Homo sapiens P07288
- Stanniocalcin-2 / Homo sapiens O76061
- SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 / Homo sapiens Q9NZC9
- Thrombopoietin / Homo sapiens P40225
- Thrombospondin-1 / Homo sapiens P07996
- Tissue-type plasminogen activator / Homo sapiens P00750
- WAP four-disulfide core domain protein 2 / Homo sapiens Q14508
- Zinc-alpha-2-glycoprotein / Homo sapiens P25311
- Low affinity immunoglobulin gamma Fc region receptor II / Mus musculus P08101
- Myelin-oligodendrocyte glycoprotein / Mus musculus Q61885
- Major prion protein (VRQ/VRQ polymorphism) 21K slow variant / Ovis aries Q712V9
- Major prion protein (VRQ/VRQ polymorphism) CH1641 variant / Ovis aries Q712V9
- Low density lipoprotein receptor-related protein 2 / Rattus norvegicus P98158
- Neuroligin 1 / Rattus norvegicus Q62765
- 32 kDa enamelin / Sus scrofa O97939
- Major seminal plasma glycoprotein psp-i / Sus scrofa P35495
- Major seminal plasma glycoprotein psp-ii / Sus scrofa P35496
- Immunoglobulin gamma / Gallus gallus
- Ancrod / Calloselasma rhodostoma P26324
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Acetabular Part of Hip Bone (UBERON_0001269) HT-1080 (CVCL_0317) Fibroblast (CL_0000057)
- Amniotic Fluid (UBERON_0000173)
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977) Mature NK T cell (CL_0000814)
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Colon (UBERON_0001155)
- Enamel Organ (UBERON_0005176)
- Kidney (UBERON_0002113) 6/9CII (CVCL_VT76)
- Kidney (UBERON_0002113) BHK570 (CVCL_6370) Fibroblast (CL_0000057)
- Kidney (UBERON_0002113) HEK293 (CVCL_0045)
- Kidney (UBERON_0002113) HEK293-EBNA (CVCL_6974)
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Seminal Fluid (UBERON_0006530)
- Skin of Body (UBERON_0002097) HMCB (CVCL_3317)
- Umbilical Vein (UBERON_0002066) HUVEC-C (CVCL_2959) Endothelial Cell of Umbilical Vein (CL_0002618)
- Urine (UBERON_0001088)
- Venom (UBERON_0007113)
- CHO (CVCL_0213)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- HEK293-F (CVCL_6642)
- HEK293T (CVCL_0063)
- Adipocytes (CL_0000136)
- Neutrophil (CL_0000775)
- Microsome (GO_0005792)
Source
- N-Linked / Complex / Gal(?1-?)GlcNAc(b1-2)Man(a1-?)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-6)]GlcNAc+"+ NeuAc(a2-6)"
- N-Linked / Complex / Structure 1134
- N-Linked / Complex / Gal(b1-3)[NeuAc(a2-6)]GlcNAc(b1-4)[GlcNAc(b1-2)]Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc(a2-6)"
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-?)[GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc+"+ NeuAc(a2-6)Gal(b1-4)"
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-?)]Man(a1-?)[GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Gal(b1-4) + NeuAc(a2-6)"
- N-Linked / Complex / GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Hex(?1-?)HexNAc(?1-?)Man(a1-?)[HexNAc(?1-?)HexNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc+"+ NeuAc"
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-3)GlcNAc(b1-2)Man(a1-3)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-3)GlcNAc(b1-2)Man(a1-6)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GalNAc(b1-?)GlcNAc(b1-2)Man(b1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[GlcNAc(b1-2)Man(a1-?)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 9263
- N-Linked / Complex / Structure 9511
- N-Linked / Complex / Structure 9607
- N-Linked / Complex / Structure 9695
- N-Linked / Complex / Structure 9733
- N-Linked / Complex / Structure 9788
- N-Linked / Complex / Structure 9935
- N-Linked / Complex / Structure 10020
- N-Linked / Complex / Structure 10110
- N-Linked / Complex / Structure 10174
- N-Linked / Complex / Structure 10191
- N-Linked / Complex / Structure 10295
- N-Linked / Complex / Structure 10697
- N-Linked / Complex / Structure 10776
- N-Linked / Complex / Structure 10935
- N-Linked / Complex / Structure 10937
- N-Linked / Complex / Structure 10987
- N-Linked / Complex / Structure 11126
- N-Linked / Complex / Structure 11162
- N-Linked / Complex / Structure 11173
- N-Linked / Complex / Structure 11214
- N-Linked / Complex / Structure 11253
- N-Linked / Complex / Structure 11406
- N-Linked / Undefined core / NeuAc(??-?)HexNAc(??-?)HexNAc(??-?)Hex(??-?)[Hex(??-?)HexNAc(??-?)Hex(??-?)]Hex(??-?)HexNAc(??-?)[Fuc(??-?)]HexNAc
- N-Linked / Undefined core / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
Reported structure
- Cancer, breast (DOID:1612)
- Control/Healthy
- COVID-19 (DOID:0080600)
- Fibrosarcoma (DOID:3355)
- Gastritis (DOID:4029)
- Hyper IgE syndrome (PGM3 mutation, p.Asp507Tyr) (DOID:0080545)
- Melanoma (DOID:1909)
- Multiple myeloma (DOID:9538)
- Oral squamous cell carcinoma (DOID:0050866)
- Prostate cancer (DOID:10283)
- Prostate Disease (DOID:47)
- Scrapie (DOID:5434)
Disease
- High-throughput glycopeptide profiling of prostate-specific antigen from seminal plasma by MALDI-MS. (2021 - Wei Wang, Anna Kałuża, Jan Nouta, Simone Nicolardi, Mirosława Ferens-Sieczkowska, Manfred Wuhrer, Guinevere S M Lageveen-Kammeijer, Noortje de Haan) / Status : Reviewed
- Site-specific analysis of N-glycans from different sheep prion strains (2021 - Natali Nakić ,Thanh Hoa Tran ,Mislav Novokmet,Olivier Andreoletti,Gordan Lauc,Giuseppe Legname) / Status : Reviewed
- Structural and functional characterization of SARS-CoV-2 RBD domains produced in mammalian cells (2021 - Christoph Gstöttner, Tao Zhang, Anja Resemann, Sophia Ruben, Stuart Pengelley, Detlev Suckau, Tim Welsink, Manfred Wuhrer, Elena Domínguez-Vega) / Status : Reviewed
- Profiling the proteoforms of urinary prostate-specific antigen by capillary electrophoresis – mass spectrometry (2021 - Alan B. Moran, Elena Domínguez-Vega, Jan Nouta, Tamas Pongracz, Theo M. de Reijke, Manfred Wuhrer, Guinevere S.M. Lageveen-Kammeijer) / Status : Reviewed
- Toward robust N-glycomics of various tissue samples that may contain glycans with unknown or unexpected structures. (2021 - Suzuki N, Abe T, Hanzawa K, Natsuka S) / Status : Reviewed
- Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity. (2021 - Cruz E, Sifniotis V, Sumer-Bayraktar Z, Reslan M, Wilkinson-White L, Cordwell S, Kayser V) / Status : Reviewed
- Bisecting GlcNAc Protein N-Glycosylation Is Characteristic of Human Adipogenesis. (2020 - Katherine Wongtrakul-Kish, Benjamin R Herbert, Nicolle H Packer) / Status : Reviewed
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Reviewed
- Comprehensive N- and O-glycosylation mapping of human coagulation factor V. (2020 - Ma C, Liu D, Li D, Zhang J, Xu XQ, Zhu H, Wan XF, Miao CH, Konkle BA, Onigman P, Xiao W, Li L) / Status : Reviewed
- Cysteine Aminoethylation Enables the Site-Specific Glycosylation Analysis of Recombinant Human Erythropoietin using Trypsin (2020 - Steffen Lippold, Alexander Büttner, Matthew S.F. Choo, Michaela Hook, Coen J. de Jong, Terry Nguyen-Khuong, Markus Haberger, Dietmar Reusch, Manfred Wuhrer, Noortje de Haan) / Status : Reviewed
- Quantitative Longitudinal Inventory of the N-Glycoproteome of Human Milk from a Single Donor Reveals the Highly Variable Repertoire and Dynamic Site-Specific Changes (2020 - Jing Zhu, Yu-Hsien Lin, Kelly A Dingess, Marko Mank, Bernd Stahl, Albert J R Heck) / Status : Reviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- A novel, ultrasensitive approach for quantitative carbohydrate composition and linkage analysis using LC-ESI ion trap tandem mass spectrometry (2019 - Kathirvel Alagesan, Daniel Varon Silva, Peter H Seeberger, Daniel Kolarich) / Status : Reviewed
- Primary Human Natural Killer Cells Retain Proinflammatory IgG1 at the Cell Surface and Express CD16a Glycoforms with Donor-dependent Variability. (2019 - Patel KR, Nott JD, Barb AW) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Tongue Cancer Patients Can be Distinguished from Healthy Controls by Specific N-Glycopeptides Found in Serum. (2018 - Mayank Saraswat, Antti Mäkitie, Tiialotta Tohmola, Amy Dickinson, Shruti Saraswat, Sakari Joenväärä, Suvi Renkonen) / Status : Reviewed
- A Microarray-Matrix-assisted Laser Desorption/Ionization-Mass Spectrometry Approach for Site-specific Protein N-glycosylation Analysis, as Demonstrated for Human Serum Immunoglobulin M (IgM) (2015 - Martin Pabst, Simon Karl Küster, Fabian Wahl, Jasmin Krismer, Petra S.Dittrich, Renato Zenobi) / Status : Reviewed
- The serum immunoglobulin G glycosylation signature of gastric cancer (2015 - L. Renee Ruhaak, Donald A. Barkauskas, Javier Torres, Cara L. Cooke, Lauren D. Wu, Carol Stroble, Sureyya Ozcan, Cynthia C. Williams, Margarita Camorlinga, David M. Rocke, Carlito B. Lebrilla, Jay V. Solnick,) / Status : Reviewed
- A single glycan on IgE is indispensable for initiation of anaphylaxis (2015 - Kai-Ting C. Shade, Barbara Platzer, Nathaniel Washburn, Vinidhra Mani, Yannic C. Bartsch, Michelle Conroy, Jose D. Pagan, Carlos Bosques, Thorsten R. Mempel, Edda Fiebiger, Robert M. Anthony) / Status : Reviewed
- Immunoglobulin G (IgG) Fab Glycosylation Analysis Using a New Mass Spectrometric High-throughput Profiling Method Reveals Pregnancy-associated Changes (2014 - Albert Bondt, Yoann Rombouts, Maurice H.J.Selman, Paul J.Hensbergen, Karli R.Reiding, Johanna M.W.Hazes, Radboud J.E.M.Dolhain, Manfred Wuhrer) / Status : Reviewed
- Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels, (2014 - Atfa Sassi, Sandra Lazaroski, Gang Wu, Stuart M. Haslam, Manfred Fliegauf, Fethi Mellouli, Turkan Patiroglu, Ekrem Unal, Mehmet Akif Ozdemir, Zineb Jouhadi, Khadija Khadir, Leila Ben-Khemis, Meriem Ben-Ali, Imen Ben-Mustapha, Lamia Borchani, Dietmar Pfeifer, Thilo Jakob, Monia Khemiri, A. Charlotta Asplund, Manuela O. Gustafsson, Karin E. Lundin, Elin Falk-Sörqvist, Lotte N. Moens, Hatice Eke Gungor, Karin R. Engelhardt, Magdalena Dziadzio, Hans Stauss, Bernhard Fleckenstein, Rebecca Meier, Khairunnadiya Prayitno, Andrea Maul-Pavicic, Sandra Schaffer, Mirzokhid Rakhmanov, Philipp Henneke, Helene Kraus, Hermann Eibel, Uwe Kölsch, Sellama Nadifi, Mats Nilsson, Mohamed Bejaoui, Alejandro A. Schäffer, C.I. Edvard Smith, Anne Dell, Mohamed-Ridha Barbouche, Bodo Grimbacher) / Status : Reviewed
- Comparison of sialylated N-glycopeptide levels in serum of pancreatic cancer patients, acute pancreatitis patients, and healthy controls (2014 - Kontro H, Joenväärä S, Haglund C, Renkonen R) / Status : Reviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Fc gamma receptor glycosylation modulates the binding of IgG glycoforms: a requirement for stable antibody interactions. (2014 - Hayes JM, Frostell A, Cosgrave EF, Struwe WB, Potter O, Davey GP, Karlsson R, Anneren C, Rudd PM) / Status : Unreviewed
- Site-specific glycan microheterogeneity of inter-alpha-trypsin inhibitor heavy chain H4 (2014 - Chandler KB, Brnakova Z, Sanda M, Wang S, Stalnaker SH, Bridger R, Zhao P, Wells L, Edwards NJ, Goldman R.) / Status : Reviewed
- Glycoproteomics: Identifying the Glycosylation of Prostate Specific Antigen at Normal and High Isoelectric Points by LC-MS/MS (2014 - Song E, Mayampurath A, Yu CY, Tang H, Mechref Y) / Status : Reviewed
- Human Serum IgM Glycosylation: IDENTIFICATION OF GLYCOFORMS THAT CAN BIND TO MANNAN-BINDING LECTIN (2005 - James N.Arnold, Mark R.Wormald, David M.Suter, Catherine M.Radcliffe, David J.Harvey, Raymond A.Dwek, Pauline M.Rudd, Robert B.Sim) / Status : Reviewed
- The Glycosylation of Human Serum IgD and IgE and the Accessibility of Identified Oligomannose Structures for Interaction with Mannan-Binding Lectin (2004 - James N. Arnold, Catherine M. Radcliffe, Mark R. Wormald, Louise Royle, David J. Harvey, Max Crispin, Raymond A. Dwek, Robert B. Sim and Pauline M. Rudd) / Status : Reviewed
- Structural characterization of recombinant soluble rat neuroligin 1: mapping of secondary structure and glycosylation by mass spectrometry. (2004 - Hoffman RC, Jennings LL, Tsigelny I, Comoletti D, Flynn RE, Sudhof TC, Taylor P) / Status : Reviewed
- Site-specific N-glycosylation of chicken serum IgG. (2004 - Suzuki N, Lee YC) / Status : Reviewed
- Characterization of the N-linked oligosaccharides of megalin (gp330) from rat kidney. (2000 - Morelle W, Haslam S, Ziak M, Roth J, Morris H, Dell A) / Status : Reviewed
- Structural characterization of the oligosaccharide chains of native and crystallized boar seminal plasma spermadhesin PSP-I and PSP-II glycoforms. (1999 - Nimtz M, Grabenhorst E, Conradt H, Sanz L, Calvete J) / Status : Reviewed
- Characterization of human vascular endothelial cadherin glycans. (1999 - Geyer H, Geyer R, Odenthal-Schnittler M, Schnittler H) / Status : Reviewed
- N-glycan structures of matrix metalloproteinase-1 derived from human fibroblasts and from HT-1080 fibrosarcoma cells. (1999 - Saarinen J, Welgus H, Flizar C, Kalkkinen N, Helin J) / Status : Reviewed
- N-glycan structures of a recombinant mouse soluble Fcgamma receptor II. (1998 - Takahashi N, Yamada W, Masuda K, Araki H, Tsukamoto Y, Galinha A, Sauts C, Kato K, Shimada I) / Status : Reviewed
- Peptide, disulfide, and glycosylation mapping of recombinant human thrombopoietin from ser1 to Arg246. (1996 - Hoffman RC, Andersen H, Walker K, Krakover JD, Patel S, Stamm MR, Osborn SG) / Status : Reviewed
- Carbohydrate moieties of porcine 32 kDa enamelin. (1995 - Yamakoshi Y) / Status : Reviewed
- Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities. (1995 - Dell A, Morris H, Easton R, Panico M, Patankar M, Oehniger S, Koistinen R, Koistinen H, Seppala M, Clark G) / Status : Reviewed
- Site-specific characterization of glycoprotein carbohydrates by exoglycosidase digestion and laser desorption mass spectrometry. (1994 - Sutton C, O'Neill J, Cottrell J) / Status : Reviewed
- Carbohydrate structure of a thrombin-like serine protease from Agkistrodon rhodostoma. Structure elucidation of oligosaccharides by methylation analysis, liquid secondary-ion mass spectrometry and proton magnetic resonance. (1992 - Pfeiffer G, Dabrowski U, Dabrowski J, Stirm S, Strube K, Geyer R) / Status : Reviewed
- A novel sialylated N-acetylgalactosamine-containing oligosaccharide is the major complex-type structure present in Bowes melanoma tissue plasminogen activator. (1991 - Chan A, Morris H, Panico M, Etienne A, Rogers M, Gaffney P, Creighton-Kempsford L, Dell A) / Status : Reviewed
Reference
- Alpha-2-macroglobulin / Homo sapiens
-
Angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
- Asporin / Homo sapiens
- Beta-hexosaminidase subunit alpha / Homo sapiens
- Biglycan / Homo sapiens
- Cadherin EGF LAG seven-pass G-type receptor 1 / Homo sapiens
-
Cadherin-5 / Homo sapiens
- Undefined site
- Calumenin / Homo sapiens
- Calumenin, isoform CRA_a / Homo sapiens
- Cartilage oligomeric matrix protein / Homo sapiens
- Cathepsin F / Homo sapiens
- CD16A-NK13-V/F genotype / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Clusterin / Homo sapiens
- Coagulation factor V / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-1(XIV) chain / Homo sapiens
- Decorin / Homo sapiens
- Desmoglein-2 / Homo sapiens
- Erythropoietin / Homo sapiens
- Extracellular matrix protein 1 / Homo sapiens
- Extracellular sulfatase Sulf-1 / Homo sapiens
- Fibromodulin / Homo sapiens
- Fibronectin / Homo sapiens
- Galectin-3-binding protein / Homo sapiens
- Glycodelin-a / Homo sapiens
-
High affinity immunoglobulin gamma Fc receptor I / Homo sapiens
- Undefined site
- HLA class I histocompatibility antigen, B-35 alpha chain / Homo sapiens
- HLA class I histocompatibility antigen, B-44 alpha chain / Homo sapiens
- HLA class I histocompatibility antigen, B-53 alpha chain / Homo sapiens
- HLA class I histocompatibility antigen, B-58 alpha chain / Homo sapiens
- HLA class I histocompatibility antigen, Cw-15 alpha chain / Homo sapiens
- HLA class I histocompatibility antigen, Cw-3 alpha chain / Homo sapiens
- Immunoglobulin epsilon chain c region / Homo sapiens
-
Immunoglobulin gamma / Homo sapiens
- Undefined site
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
-
Immunoglobulin heavy constant delta / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant delta - heavy chain 1 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant delta - heavy chain 2 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant epsilon - heavy chain 1 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant epsilon - heavy chain 2 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant A121N / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant T198N / Homo sapiens
- Undefined site
- Immunoglobulin heavy constant mu / Homo sapiens
- Immunoglobulin J chain / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens
- Interstitial collagenase / Homo sapiens
- Keratin, type II cytoskeletal 8 / Homo sapiens
- Kininogen-1 / Homo sapiens
- Lactotransferrin / Homo sapiens
- Laminin subunit alpha-4 / Homo sapiens
-
Low affinity immunoglobulin gamma Fc region receptor II-a (FcγRIIa ) / Homo sapiens
- Undefined site
-
Low affinity immunoglobulin gamma Fc region receptor II-b (FcγRIIb ) / Homo sapiens
- Undefined site
-
Low affinity immunoglobulin gamma Fc region receptor III-A (FcγRIIIa ) / Homo sapiens
- Undefined site
-
Low affinity immunoglobulin gamma Fc region receptor III-B (FcγRIIIb ) / Homo sapiens
- Undefined site
- Lumican / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Matrilin-4 / Homo sapiens
- Mesothelin / Homo sapiens
- Metalloproteinase inhibitor 1 / Homo sapiens
- Nephronectin / Homo sapiens
- Olfactomedin-like protein 3 / Homo sapiens
- Palmitoyl-protein thioesterase 1 / Homo sapiens
- Periostin / Homo sapiens
- Phospholipase B-like 1 / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 / Homo sapiens
- Prominin-1 / Homo sapiens
- Prosaposin / Homo sapiens
- Prostaglandin F2 receptor negative regulator / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Prostate-specific antigen (psa-1) / Homo sapiens
- Prostate-specific antigen - high Pi isoform (psah) / Homo sapiens
- Stanniocalcin-2 / Homo sapiens
- SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 / Homo sapiens
-
Thrombopoietin / Homo sapiens
- Undefined site
- Thrombospondin-1 / Homo sapiens
- Tissue-type plasminogen activator / Homo sapiens
- WAP four-disulfide core domain protein 2 / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
-
Low affinity immunoglobulin gamma Fc region receptor II / Mus musculus
- Undefined site
- Myelin-oligodendrocyte glycoprotein / Mus musculus
- Major prion protein (VRQ/VRQ polymorphism) 21K slow variant / Ovis aries
- Major prion protein (VRQ/VRQ polymorphism) CH1641 variant / Ovis aries
-
Low density lipoprotein receptor-related protein 2 / Rattus norvegicus
- Undefined site
-
Neuroligin 1 / Rattus norvegicus
- Undefined site
-
32 kDa enamelin / Sus scrofa
- Undefined site
- Major seminal plasma glycoprotein psp-i / Sus scrofa
- Major seminal plasma glycoprotein psp-ii / Sus scrofa
-
Immunoglobulin gamma / Gallus gallus
- Undefined site
-
Ancrod / Calloselasma rhodostoma
- Undefined site
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- NSGALTSGVHTFPAVLQSSGLY (22aa)
- SLSSVVTVPSSSLGTQTY (18aa)
- QCVNLTTR (8aa)
- TAVNCSSDFDACLITK (16aa)
- TGVCPELQADQNCTQECVSDSECADNLK (28aa)
- KNNSDISSTRG (11aa)
- WFSAGLASNSSWLR (14aa)
- FVGTPEVNQTTIYQR (15aa)
- YETTNK (6aa)
- NATGMEVGWYR (11aa)
- SLNENITVPDTK (12aa)
- AVCGGVLVHPQWVLTAAHCIRNK (23aa)
- AVCGGVLVHPQWVLTAAHCIRNKSVILLGR (30aa)
- NKSVLLGR (8aa)
- GLNVGPNATR (10aa)
- NK (2aa)
- RIIVPLNNRENISDPTSPLRT (21aa)
- LSLQNTAEIQHCLVNAGDVGCGVFECFENNSCEIR (35aa)
- HAIHVSGTNGTKRF (14aa)
- FHAIHVSGTNGTKRF (15aa)
- SVVAPATDGGLNLTSTFLRK (20aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- AFENVTDLQWLILDHNLLENSK (22aa)
- AIIQGLMPDQNYTVQIIAYNK (21aa)
- AIIQGLMPDQNYTVQIIAYNKDK (23aa)
- ELPGVCNETMMALWEECKPCLK (22aa)
- DIVEYYNDSNGSHVIQGR (18aa)
- YYNQSEAGSHIIQR (14aa)
- P04222 Asn-110     HLA class I histocompatibility antigen, Cw-3 alpha chain / Homo sapiens
- Q07000 Asn-110     HLA class I histocompatibility antigen, Cw-15 alpha chain / Homo sapiens
- P10319 Asn-110     HLA class I histocompatibility antigen, B-58 alpha chain / Homo sapiens
- P30481 Asn-110     HLA class I histocompatibility antigen, B-44 alpha chain / Homo sapiens
- P30491 Asn-110     HLA class I histocompatibility antigen, B-53 alpha chain / Homo sapiens
- P30685 Asn-110     HLA class I histocompatibility antigen, B-35 alpha chain / Homo sapiens
- CGPCPAGFTGNGSHCTDVNECNAHPCFPR (29aa)
- TQSLLIVNNATNVVIK (16aa)
- KLHINHNNLTESVGPLPK (18aa)
- LHINHNNLTESVGPLPK (17aa)
- FGCEIENNR (9aa)
- NVTYGTYIDDPDPDDGFNYK (20aa)
- NATYGYVIDDPDPDDGFNYK (20aa)
- YHKNNKSWMESEF (13aa)
- SAEGTFFINK (10aa)
- IYIDHNNITR (10aa)
- IYVIDGTQNDTAFVFPR (17aa)
- CRGLVGSKNVSSE (13aa)
- INATDADEPNTINSK (15aa)
- YPNQVYYRPVDQYSNQNNFVHDCVNITVK (29aa)
- QIGLYPVLVIDSSGYVNPNYTGR (23aa)
- NFVITYNR (8aa)
- ASPSGQNISYIHSSSESVTPRTEGR (25aa)
- TPLTANITK (9aa)
- GLTFQQNASSM(SO)CVPDQDTAIR (25aa)
- GLTFQQNASSMCVPDQDTAIR (21aa)
- RGLTFQQNASSMCVPDQDTAIRV (23aa)
- EAINITIDHK (10aa)
- GITFQQNASSMCVPDQDTAIR (21aa)
- GINESYKK (8aa)
- TNSTFVQALVEHVK (14aa)
- NTTGFK (6aa)
- GCSSSTSVLLTLDNNVVNGSSPAIR (25aa)
- FHLANR (6aa)
- ISHNEIADSGIPGNSFNVSSIVEIDISYNK (30aa)
- LGLSFNSISAVDNGSLANTPH (21aa)
- GLSFNSISAVDNGSLANTPHLR (22aa)
- IGISFNSISAVDNGSIANTPHIR (23aa)
- MIENGSISFIPTIR (14aa)
- THTNISE (7aa)
- GNGTILK (7aa)
- EALENMNSTLK (11aa)
- ITDIENGSIANIPR (14aa)
- NVSVAEGK (8aa)
- LNAENNATFYFK (12aa)
- IIQVVYIHSNNITK (14aa)
- LQVVYLHSNNITK (13aa)
- FPNIT (5aa)
- RFPNIT (6aa)
- FPNITNLCPFGE (12aa)
- LAGKPTHVNVSVVMAEVDGTC (21aa)
- IAGKPTHVNVSVVMAEVDGTCY (22aa)
- KTIDRLAGKPTHVNVSVVMAEVDGTCY- (28aa)
- RLAGKPTHVNVSVVMAEVDGTCY- (24aa)
- VFNATR (6aa)
- GEVFNATR (8aa)
- NATRF (5aa)
- QGNNHTCTWK (10aa)
- KVSCPIMPCSNATVPDGECCPR (22aa)
- IANITQGEDQYYIR (14aa)
- VLGGAWDVFQLNESSGVVSTR (21aa)
- NMSIHTK (7aa)
- IYNWSGYPIIVQK (13aa)
- GGNSNGAICHFPFIYNNHNYTDCTSEGRR (29aa)
- LAFQNMNGSEYFVK (14aa)
- TAGWNIPMGIIFNQTGSCK (19aa)
- DQCIVDDITYNVNDTFHK (18aa)
- AAIPSAIDTNSSK (13aa)
- EVNDTLLVNELK (12aa)
- LYQDVNCT (8aa)
- CFILPNDSIHCER (13aa)
- VPAQEKNF (8aa)
- NGTHWFV (7aa)
- NGTHWFVT (8aa)
- NQTLSLFFTVLQDVPVR (17aa)
- EAGNITTDGYEIIGK (15aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Melanoma (DOID:1909)
- Tissue-type plasminogen activator / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Kidney (UBERON_0002113) HEK293 (CVCL_0045)
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Enamel Organ (UBERON_0005176)
- Carbohydrate moieties of porcine 32 kDa enamelin. (1995 - Yamakoshi Y) / Status : Reviewed
-
32 kDa enamelin / Sus scrofa
- Undefined site
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Fibrosarcoma (DOID:3355)
- Interstitial collagenase / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Amniotic Fluid (UBERON_0000173)
- Glycodelin-a / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Metalloproteinase inhibitor 1 / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Umbilical Vein (UBERON_0002066) HUVEC-C (CVCL_2959) Endothelial Cell of Umbilical Vein (CL_0002618)
-
Cadherin-5 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2119.9608)
- A novel, ultrasensitive approach for quantitative carbohydrate composition and linkage analysis using LC-ESI ion trap tandem mass spectrometry (2019 - Kathirvel Alagesan, Daniel Varon Silva, Peter H Seeberger, Daniel Kolarich) / Status : Reviewed
- Site-specific N-glycosylation of chicken serum IgG. (2004 - Suzuki N, Lee YC) / Status : Reviewed
-
Immunoglobulin heavy constant delta / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant delta - heavy chain 1 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant delta - heavy chain 2 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant epsilon - heavy chain 1 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant epsilon - heavy chain 2 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant mu / Homo sapiens
- Undefined site
-
Immunoglobulin gamma / Gallus gallus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2119.9608)
-
Neuroligin 1 / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Venom (UBERON_0007113)
-
Ancrod / Calloselasma rhodostoma
- Undefined site
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Venom (UBERON_0007113)
-
Ancrod / Calloselasma rhodostoma
- Undefined site
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Kidney (UBERON_0002113) 6/9CII (CVCL_VT76)
-
Low affinity immunoglobulin gamma Fc region receptor II / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Seminal Fluid (UBERON_0006530)
- Major seminal plasma glycoprotein psp-i / Sus scrofa
- Major seminal plasma glycoprotein psp-ii / Sus scrofa
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Microsome (GO_0005792)
-
Low density lipoprotein receptor-related protein 2 / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Erythropoietin / Homo sapiens
- SLNENITVPDTK (12aa)
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Milk (UBERON_0001913)
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Immunoglobulin J chain / Homo sapiens
- KNNSDISSTRG (11aa)
- RIIVPLNNRENISDPTSPLRT (21aa)
- RGLTFQQNASSMCVPDQDTAIRV (23aa)
- KTIDRLAGKPTHVNVSVVMAEVDGTCY- (28aa)
- RLAGKPTHVNVSVVMAEVDGTCY- (24aa)
-
- N-Linked / Complex
(avg mass : 2119.9608)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
-
Angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Seminal Fluid (UBERON_0006530)
- Prostate-specific antigen (psa-1) / Homo sapiens
- NK (2aa)
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Adipocytes (CL_0000136)
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Seminal Fluid (UBERON_0006530)
- Prostate-specific antigen (psa-1) / Homo sapiens
- NK (2aa)
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Brain (UBERON_0000955)
- Scrapie (DOID:5434)
- Major prion protein (VRQ/VRQ polymorphism) 21K slow variant / Ovis aries
- Major prion protein (VRQ/VRQ polymorphism) CH1641 variant / Ovis aries
- YPNQVYYRPVDQYSNQNNFVHDCVNITVK (29aa)
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Reviewed
- A Microarray-Matrix-assisted Laser Desorption/Ionization-Mass Spectrometry Approach for Site-specific Protein N-glycosylation Analysis, as Demonstrated for Human Serum Immunoglobulin M (IgM) (2015 - Martin Pabst, Simon Karl Küster, Fabian Wahl, Jasmin Krismer, Petra S.Dittrich, Renato Zenobi) / Status : Reviewed
- The serum immunoglobulin G glycosylation signature of gastric cancer (2015 - L. Renee Ruhaak, Donald A. Barkauskas, Javier Torres, Cara L. Cooke, Lauren D. Wu, Carol Stroble, Sureyya Ozcan, Cynthia C. Williams, Margarita Camorlinga, David M. Rocke, Carlito B. Lebrilla, Jay V. Solnick,) / Status : Reviewed
-
Immunoglobulin gamma / Homo sapiens
- Undefined site
- Immunoglobulin heavy constant mu / Homo sapiens
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TQSLLIVNNATNVVIK (16aa)
- GLTFQQNASSM(SO)CVPDQDTAIR (25aa)
- GLTFQQNASSMCVPDQDTAIR (21aa)
- THTNISE (7aa)
- FPNITNLCPFGE (12aa)
- VFNATR (6aa)
-
- N-Linked / Complex
(avg mass : 2119.9608)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
- GEVFNATR (8aa)
-
- N-Linked / Complex
(avg mass : 2119.9608)
- HEK293T (CVCL_0063)
- Immunoglobulin epsilon chain c region / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Blood Serum (UBERON_0001977)
- Control/Healthy
- Human Serum IgM Glycosylation: IDENTIFICATION OF GLYCOFORMS THAT CAN BIND TO MANNAN-BINDING LECTIN (2005 - James N.Arnold, Mark R.Wormald, David M.Suter, Catherine M.Radcliffe, David J.Harvey, Raymond A.Dwek, Pauline M.Rudd, Robert B.Sim) / Status : Reviewed
- The Glycosylation of Human Serum IgD and IgE and the Accessibility of Identified Oligomannose Structures for Interaction with Mannan-Binding Lectin (2004 - James N. Arnold, Catherine M. Radcliffe, Mark R. Wormald, Louise Royle, David J. Harvey, Max Crispin, Raymond A. Dwek, Robert B. Sim and Pauline M. Rudd) / Status : Reviewed
-
Immunoglobulin heavy constant delta / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant mu / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Neutrophil (CL_0000775)
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Urine (UBERON_0001088)
- Prostate-specific antigen (psa-1) / Homo sapiens
- NK (2aa)
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Urine (UBERON_0001088)
- Prostate-specific antigen (psa-1) / Homo sapiens
- NK (2aa)
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Blood Plasma (UBERON_0001969)
-
Immunoglobulin heavy constant delta / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant epsilon - heavy chain 1 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant epsilon - heavy chain 2 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Blood Plasma (UBERON_0001969)
- Multiple myeloma (DOID:9538)
-
Immunoglobulin heavy constant mu / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Seminal Fluid (UBERON_0006530)
- Prostate-specific antigen (psa-1) / Homo sapiens
- Prostate-specific antigen - high Pi isoform (psah) / Homo sapiens
- AVCGGVLVHPQWVLTAAHCIRNK (23aa)
- AVCGGVLVHPQWVLTAAHCIRNKSVILLGR (30aa)
- NKSVLLGR (8aa)
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Colon (UBERON_0001155)
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Colon (UBERON_0001155)
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Toward robust N-glycomics of various tissue samples that may contain glycans with unknown or unexpected structures. (2021 - Suzuki N, Abe T, Hanzawa K, Natsuka S) / Status : Reviewed
- Primary Human Natural Killer Cells Retain Proinflammatory IgG1 at the Cell Surface and Express CD16a Glycoforms with Donor-dependent Variability. (2019 - Patel KR, Nott JD, Barb AW) / Status : Unreviewed
- CD16A-NK13-V/F genotype / Homo sapiens
- CRGLVGSKNVSSE (13aa)
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Blood Plasma (UBERON_0001969)
- Coagulation factor V / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2119.9608)
- HEK293-F (CVCL_6642)
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant A121N / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant L177N / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant gamma 1 (Trastuzumab) mutant T198N / Homo sapiens
- Undefined site
- NSGALTSGVHTFPAVLQSSGLY (22aa)
- SLSSVVTVPSSSLGTQTY (18aa)
-
- N-Linked / Complex
(avg mass : 2119.9608)
- HEK293 (CVCL_0045)
-
High affinity immunoglobulin gamma Fc receptor I / Homo sapiens
- Undefined site
-
Low affinity immunoglobulin gamma Fc region receptor II-a (FcγRIIa ) / Homo sapiens
- Undefined site
-
Low affinity immunoglobulin gamma Fc region receptor II-b (FcγRIIb ) / Homo sapiens
- Undefined site
-
Low affinity immunoglobulin gamma Fc region receptor III-A (FcγRIIIa ) / Homo sapiens
- Undefined site
-
Low affinity immunoglobulin gamma Fc region receptor III-B (FcγRIIIb ) / Homo sapiens
- Undefined site
-
- N-Linked / Undefined core
(avg mass : 2119.9608)
- Blood Serum (UBERON_0001977)
- SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 / Homo sapiens
- ASPSGQNISYIHSSSESVTPRTEGR (25aa)
-
- N-Linked / Undefined core
(avg mass : 2119.9608)
-
Thrombopoietin / Homo sapiens
- Undefined site
-
- Hex:4 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2119.9608)
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Mammary Gland (UBERON_0001911)
- Urine (UBERON_0001088)
- CHO (CVCL_0213)
- FreeStyle 293-F (CVCL_D603)
- N-Linked / Complex / Gal(?1-?)GlcNAc(b1-2)Man(a1-?)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-6)]GlcNAc+"+ NeuAc(a2-6)"
- N-Linked / Complex / Structure 1134
- N-Linked / Complex / Gal(b1-3)[NeuAc(a2-6)]GlcNAc(b1-4)[GlcNAc(b1-2)]Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc(a2-6)"
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-?)[GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc+"+ NeuAc(a2-6)Gal(b1-4)"
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-?)]Man(a1-?)[GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Gal(b1-4) + NeuAc(a2-6)"
- N-Linked / Complex / GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Hex(?1-?)HexNAc(?1-?)Man(a1-?)[HexNAc(?1-?)HexNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc+"+ NeuAc"
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-3)GlcNAc(b1-2)Man(a1-3)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-3)GlcNAc(b1-2)Man(a1-6)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GalNAc(b1-?)GlcNAc(b1-2)Man(b1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[GlcNAc(b1-2)Man(a1-?)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 9263
- N-Linked / Complex / Structure 9511
- N-Linked / Complex / Structure 9607
- N-Linked / Complex / Structure 9695
- N-Linked / Complex / Structure 9733
- N-Linked / Complex / Structure 9788
- N-Linked / Complex / Structure 9935
- N-Linked / Complex / Structure 10020
- N-Linked / Complex / Structure 10110
- N-Linked / Complex / Structure 10174
- N-Linked / Complex / Structure 10191
- N-Linked / Complex / Structure 10295
- N-Linked / Complex / Structure 10697
- N-Linked / Complex / Structure 10776
- N-Linked / Complex / Structure 10935
- N-Linked / Complex / Structure 10937
- N-Linked / Complex / Structure 10987
- N-Linked / Complex / Structure 11126
- N-Linked / Complex / Structure 11162
- N-Linked / Complex / Structure 11173
- N-Linked / Complex / Structure 11214
- N-Linked / Complex / Structure 11253
- N-Linked / Complex / Structure 11406
- N-Linked / Undefined core / NeuAc(??-?)HexNAc(??-?)HexNAc(??-?)Hex(??-?)[Hex(??-?)HexNAc(??-?)Hex(??-?)]Hex(??-?)HexNAc(??-?)[Fuc(??-?)]HexNAc
- N-Linked / Undefined core / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- Cancer, breast (DOID:1612)
- Control/Healthy
- COVID-19 (DOID:0080600)
- Prostate cancer (DOID:10283)
- Structural and functional characterization of SARS-CoV-2 RBD domains produced in mammalian cells (2021 - Christoph Gstöttner, Tao Zhang, Anja Resemann, Sophia Ruben, Stuart Pengelley, Detlev Suckau, Tim Welsink, Manfred Wuhrer, Elena Domínguez-Vega) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Immunoglobulin G (IgG) Fab Glycosylation Analysis Using a New Mass Spectrometric High-throughput Profiling Method Reveals Pregnancy-associated Changes (2014 - Albert Bondt, Yoann Rombouts, Maurice H.J.Selman, Paul J.Hensbergen, Karli R.Reiding, Johanna M.W.Hazes, Radboud J.E.M.Dolhain, Manfred Wuhrer) / Status : Reviewed
- Comparison of sialylated N-glycopeptide levels in serum of pancreatic cancer patients, acute pancreatitis patients, and healthy controls (2014 - Kontro H, Joenväärä S, Haglund C, Renkonen R) / Status : Reviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Alpha-2-macroglobulin / Homo sapiens
- Asporin / Homo sapiens
- Beta-hexosaminidase subunit alpha / Homo sapiens
- Biglycan / Homo sapiens
- Cadherin EGF LAG seven-pass G-type receptor 1 / Homo sapiens
- Calumenin / Homo sapiens
- Calumenin, isoform CRA_a / Homo sapiens
- Cartilage oligomeric matrix protein / Homo sapiens
- Cathepsin F / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Clusterin / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-1(XIV) chain / Homo sapiens
- Decorin / Homo sapiens
- Desmoglein-2 / Homo sapiens
- Extracellular matrix protein 1 / Homo sapiens
- Extracellular sulfatase Sulf-1 / Homo sapiens
- Fibromodulin / Homo sapiens
- Fibronectin / Homo sapiens
- Galectin-3-binding protein / Homo sapiens
- HLA class I histocompatibility antigen, B-35 alpha chain / Homo sapiens
- HLA class I histocompatibility antigen, B-44 alpha chain / Homo sapiens
- HLA class I histocompatibility antigen, B-53 alpha chain / Homo sapiens
- HLA class I histocompatibility antigen, B-58 alpha chain / Homo sapiens
- HLA class I histocompatibility antigen, Cw-15 alpha chain / Homo sapiens
- HLA class I histocompatibility antigen, Cw-3 alpha chain / Homo sapiens
-
Immunoglobulin gamma / Homo sapiens
- Undefined site
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Keratin, type II cytoskeletal 8 / Homo sapiens
- Kininogen-1 / Homo sapiens
- Lactotransferrin / Homo sapiens
- Laminin subunit alpha-4 / Homo sapiens
- Lumican / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Matrilin-4 / Homo sapiens
- Mesothelin / Homo sapiens
- Metalloproteinase inhibitor 1 / Homo sapiens
- Nephronectin / Homo sapiens
- Olfactomedin-like protein 3 / Homo sapiens
- Palmitoyl-protein thioesterase 1 / Homo sapiens
- Periostin / Homo sapiens
- Phospholipase B-like 1 / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 / Homo sapiens
- Prominin-1 / Homo sapiens
- Prosaposin / Homo sapiens
- Prostaglandin F2 receptor negative regulator / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Stanniocalcin-2 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- WAP four-disulfide core domain protein 2 / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
- Myelin-oligodendrocyte glycoprotein / Mus musculus
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- QCVNLTTR (8aa)
- TAVNCSSDFDACLITK (16aa)
- TGVCPELQADQNCTQECVSDSECADNLK (28aa)
- WFSAGLASNSSWLR (14aa)
- FVGTPEVNQTTIYQR (15aa)
- YETTNK (6aa)
- NATGMEVGWYR (11aa)
- GLNVGPNATR (10aa)
- LSLQNTAEIQHCLVNAGDVGCGVFECFENNSCEIR (35aa)
- HAIHVSGTNGTKRF (14aa)
- FHAIHVSGTNGTKRF (15aa)
- SVVAPATDGGLNLTSTFLRK (20aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- AFENVTDLQWLILDHNLLENSK (22aa)
- AIIQGLMPDQNYTVQIIAYNK (21aa)
- AIIQGLMPDQNYTVQIIAYNKDK (23aa)
- ELPGVCNETMMALWEECKPCLK (22aa)
- DIVEYYNDSNGSHVIQGR (18aa)
- YYNQSEAGSHIIQR (14aa)
- P04222 Asn-110     HLA class I histocompatibility antigen, Cw-3 alpha chain / Homo sapiens
- Q07000 Asn-110     HLA class I histocompatibility antigen, Cw-15 alpha chain / Homo sapiens
- P10319 Asn-110     HLA class I histocompatibility antigen, B-58 alpha chain / Homo sapiens
- P30481 Asn-110     HLA class I histocompatibility antigen, B-44 alpha chain / Homo sapiens
- P30491 Asn-110     HLA class I histocompatibility antigen, B-53 alpha chain / Homo sapiens
- P30685 Asn-110     HLA class I histocompatibility antigen, B-35 alpha chain / Homo sapiens
- CGPCPAGFTGNGSHCTDVNECNAHPCFPR (29aa)
- KLHINHNNLTESVGPLPK (18aa)
- LHINHNNLTESVGPLPK (17aa)
- FGCEIENNR (9aa)
- NVTYGTYIDDPDPDDGFNYK (20aa)
- NATYGYVIDDPDPDDGFNYK (20aa)
- YHKNNKSWMESEF (13aa)
- SAEGTFFINK (10aa)
- IYIDHNNITR (10aa)
- IYVIDGTQNDTAFVFPR (17aa)
- INATDADEPNTINSK (15aa)
- QIGLYPVLVIDSSGYVNPNYTGR (23aa)
- NFVITYNR (8aa)
- TPLTANITK (9aa)
- GLTFQQNASSMCVPDQDTAIR (21aa)
- EAINITIDHK (10aa)
- GITFQQNASSMCVPDQDTAIR (21aa)
- GINESYKK (8aa)
- NTTGFK (6aa)
- TNSTFVQALVEHVK (14aa)
- GCSSSTSVLLTLDNNVVNGSSPAIR (25aa)
- FHLANR (6aa)
- ISHNEIADSGIPGNSFNVSSIVEIDISYNK (30aa)
- LGLSFNSISAVDNGSLANTPH (21aa)
- GLSFNSISAVDNGSLANTPHLR (22aa)
- IGISFNSISAVDNGSIANTPHIR (23aa)
- MIENGSISFIPTIR (14aa)
- GNGTILK (7aa)
- EALENMNSTLK (11aa)
- ITDIENGSIANIPR (14aa)
- NVSVAEGK (8aa)
- LNAENNATFYFK (12aa)
- IIQVVYIHSNNITK (14aa)
- LQVVYLHSNNITK (13aa)
- RFPNIT (6aa)
- LAGKPTHVNVSVVMAEVDGTC (21aa)
- IAGKPTHVNVSVVMAEVDGTCY (22aa)
- GEVFNATR (8aa)
- NATRF (5aa)
- QGNNHTCTWK (10aa)
- KVSCPIMPCSNATVPDGECCPR (22aa)
- IANITQGEDQYYIR (14aa)
- VLGGAWDVFQLNESSGVVSTR (21aa)
- NMSIHTK (7aa)
- IYNWSGYPIIVQK (13aa)
- GGNSNGAICHFPFIYNNHNYTDCTSEGRR (29aa)
- LAFQNMNGSEYFVK (14aa)
- TAGWNIPMGIIFNQTGSCK (19aa)
- DQCIVDDITYNVNDTFHK (18aa)
- AAIPSAIDTNSSK (13aa)
- EVNDTLLVNELK (12aa)
- LYQDVNCT (8aa)
- CFILPNDSIHCER (13aa)
- VPAQEKNF (8aa)
- NGTHWFV (7aa)
- NGTHWFVT (8aa)
- NQTLSLFFTVLQDVPVR (17aa)
- EAGNITTDGYEIIGK (15aa)
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2119.9608)
Reported glycosite
- N-Linked / Undefined core
(avg mass : 2119.9608)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Undefined core
(avg mass : 2119.9608)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Reference
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2119.9608)
Reference
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)